211 related articles for article (PubMed ID: 18195710)
21. Methylation-associated silencing of TU3A in human cancers.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
[TBL] [Abstract][Full Text] [Related]
22. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
23. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M
Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide promoter methylome of small renal masses.
Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
[TBL] [Abstract][Full Text] [Related]
25. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.
Zhang Y; Yuan Y; Liang P; Guo X; Ying Y; Shu XS; Gao M; Cheng Y
Oncotarget; 2017 May; 8(18):30008-30018. PubMed ID: 28404905
[TBL] [Abstract][Full Text] [Related]
26. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.
Bennett KL; Campbell R; Ganapathi S; Zhou M; Rini B; Ganapathi R; Neumann HP; Eng C
Genes Chromosomes Cancer; 2011 Aug; 50(8):654-61. PubMed ID: 21584899
[TBL] [Abstract][Full Text] [Related]
27. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target.
Liu Q; Jin J; Ying J; Cui Y; Sun M; Zhang L; Fan Y; Xu B; Zhang Q
Oncotarget; 2015 Sep; 6(26):22706-23. PubMed ID: 26093088
[TBL] [Abstract][Full Text] [Related]
29. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.
Ge P; Yu X; Wang ZC; Lin J
Asian Pac J Cancer Prev; 2015; 16(9):4071-5. PubMed ID: 25987089
[TBL] [Abstract][Full Text] [Related]
30. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.
Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
Oncogene; 2002 May; 21(19):3020-8. PubMed ID: 12082532
[TBL] [Abstract][Full Text] [Related]
31. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.
Margetts CD; Morris M; Astuti D; Gentle DC; Cascon A; McRonald FE; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
Endocr Relat Cancer; 2008 Sep; 15(3):777-86. PubMed ID: 18499731
[TBL] [Abstract][Full Text] [Related]
33. Multigene methylation analysis of conventional renal cell carcinoma.
Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
[TBL] [Abstract][Full Text] [Related]
34. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
Wagner KJ; Cooper WN; Grundy RG; Caldwell G; Jones C; Wadey RB; Morton D; Schofield PN; Reik W; Latif F; Maher ER
Oncogene; 2002 Oct; 21(47):7277-82. PubMed ID: 12370819
[TBL] [Abstract][Full Text] [Related]
35. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel VHL target genes and relationship to hypoxic response pathways.
Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
[TBL] [Abstract][Full Text] [Related]
37. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
39. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.
Seliger B; Handke D; Schabel E; Bukur J; Lichtenfels R; Dammann R
J Transl Med; 2009 Oct; 7():90. PubMed ID: 19857250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
